Papi A, Caramori G, Adcock IM, Barnes PJ. Rescue treatment in asthma: more than as-needed bronchodilation. Chest, 2009, 135: 1628-1633.
Papi A, Canonica G, Maestrelli P, Paggiaro P, Olivieri D, Pozzi E et al. Rescue use of beclomethasone and albuterol in as a single inhaler for mild asthma. N Engl J Med, 2007, 356: 2040-2052.
Papi A, Canonica GW, Maestrelli P, Paggiaro P, Olivieri D, Pozzi E et al. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. N Engl J Med, 2007, 356(20): 2040-2052. doi: 10.1056/ NEJMoa063861..
DOI: 10.1056/ NEJMoa063861
Calhoun WJ, Ameredes BT, King TS, Icitovic N, Bleecker ER, Castro M et al. Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT ran-domized controlled trial. JAMA, 2012, 308(10): 987-997. doi: 10. 1001/2012.jama.10893..
DOI: 10. 1001/2012.jama.10893
Martinez FD, Chinchilli VM, Morgan WJ, Boehmer SJ, Lemanske RF Jr, Mauger DT et al. Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial. Lancet, 2011, 377: 650-657.
Haahtela T, Tamminen K, Malmberg LP, Zetterstrom O, Karjalainen J, Yla-Outinen H et al. Formoterol as needed with or without budesonide in patients with intermittent asthma and raised NO levels in exhaled air: a SOMA study. Eur Respir J, 2006, 28(4): 748-755. doi: 10.1183/09031936.06.00128005..
DOI: 10.1183/09031936.06.00128005
Rabe KF, Atienza T, Magyar P, Larsson P, Jorup C, Lalloo UG. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet, 2006, 368(9537): 744-753. doi: 10.1016/S0140-6736(06)69284-2..
DOI: 10.1016/S0140-6736(06)69284-2
Papi A, Caramori G, Adcock IM, Barnes PJ. Rescue treatment in asthma. More than as-needed bronchodilation. Chest, 2009, 135(6): 1628-1633. doi: 10. 1378/chest.08-2536..
DOI: 10. 1378/chest.08-2536
Beasley R, Weatherall M, Shirtcliffe P, Hancox R, Reddel HK. Combination corticosteroid/ beta-agonist inhaler as reliever therapy: a solution for intermittent and mild asthma? J Allergy Clin Immunol, 2014, 133(1): 39-41. doi:
1016/j. jaci.2013.10.053.
Beasley R, Roche W, Roberts J, Holgate S. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis, 1989, 139: 806-817.
Pauwels RA, Pedersen S, Busse WW, Tan WC, Chen YZ, Ohlsson SV et al. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet, 2003, 361: 1071-1076.
Reddel HK, Taylor DR, Bateman ED, Boulet L-P, Boushey HA, Busse WW et al. An official American Thoracic Society/European Respiratory Society Statement: asthma control and exacerbations: standardizing endpoints for clinical trials and clinical practice. Am J Respir Crit Care Med, 2009, 180: 59-99.
Chowdhury BA, Seymour SM, Levenson MS. Assessing the safety of adding LABAs to inhaled corticosteroids for treatment asthma. N Engl J Med, 2011, 364: 2473-2475.
O’Byrne P, J FitzGerald M, Zhong N, Bateman E, Barnes P, Keen C, Almqvist G, Pemberton K, Jorup C, Ivanov S, Reddel H. The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given ‘as needed’ in mild asthma: study protocols for two randomised controlled trials. Trials, 2017 Jan 10, 18(1): 1-13.